Cite
Study Results from Brown University Update Understanding of Cholangiocarcinoma (Elevated 2-oxoglutarate Antagonizes Dna Damage Responses In Cholangiocarcinoma Chemotherapy Through Regulating Aspartate Beta-hydroxylase)
MLA
“Study Results from Brown University Update Understanding of Cholangiocarcinoma (Elevated 2-Oxoglutarate Antagonizes Dna Damage Responses In Cholangiocarcinoma Chemotherapy Through Regulating Aspartate Beta-Hydroxylase).” Obesity, Fitness & Wellness Week, Jan. 2024, p. 2823. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.779315471&authtype=sso&custid=ns315887.
APA
Study Results from Brown University Update Understanding of Cholangiocarcinoma (Elevated 2-oxoglutarate Antagonizes Dna Damage Responses In Cholangiocarcinoma Chemotherapy Through Regulating Aspartate Beta-hydroxylase). (2024, January 20). Obesity, Fitness & Wellness Week, 2823.
Chicago
Obesity, Fitness & Wellness Week. 2024. “Study Results from Brown University Update Understanding of Cholangiocarcinoma (Elevated 2-Oxoglutarate Antagonizes Dna Damage Responses In Cholangiocarcinoma Chemotherapy Through Regulating Aspartate Beta-Hydroxylase),” January 20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.779315471&authtype=sso&custid=ns315887.